Form 4: DaVita Inc. Executive James O. Hearty Reports Changes in Beneficial Ownership
SEC Form 4 Filing
James O. Hearty, Chief Compliance Officer of DaVita Inc., reports acquisition and disposal of common stock and stock appreciation rights on March 15, 2025.
Summary
- On March 15, 2025, James O. Hearty, Chief Compliance Officer of DaVita Inc., reported transactions involving the company's common stock and stock appreciation rights.
- Hearty acquired 1,185 shares of common stock and 3,281 stock appreciation rights.
- He also disposed of shares to satisfy tax withholding obligations related to vesting performance stock units and restricted stock units.
- The disposals involved 866 shares, 846 shares, 306 shares, and 301 shares, all at a price of $143.45.
- Following these transactions, Hearty directly owns 28,389 shares of common stock and 3,281 stock appreciation rights.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing simply reports transactions related to stock awards and tax obligations, which are routine.
Positives
- The acquisition of 1,185 shares of common stock and 3,281 stock appreciation rights could be interpreted as a sign of confidence in the company's future performance.
Future Outlook
The stock appreciation rights are scheduled to vest 50% each on March 15, 2028 and March 15, 2029, subject to the terms and conditions of the applicable award agreement.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive compensation practices, including the use of stock options and restricted stock units, are common across publicly traded companies, particularly in the healthcare sector.
- Companies like Fresenius Medical Care and Baxter International also utilize similar equity-based compensation plans for their executives.
- The vesting schedules and terms of these awards are generally aligned with industry norms to incentivize long-term performance and retention.
Stakeholder Impact
- The transactions reported in this filing have a minimal direct impact on stakeholders.
- However, transparency in executive compensation is important for maintaining investor confidence.
Key Dates
| Date | Description |
|---|---|
| 03/15/2021 | Grant date of performance stock units and restricted stock units related to tax withholding obligations. |
| 03/15/2022 | Grant date of performance stock units and restricted stock units related to tax withholding obligations. |
| 03/15/2025 | Date of the reported transactions: acquisition and disposal of common stock and stock appreciation rights. |
| 03/15/2028 | First vesting date (50%) for the stock appreciation rights and restricted stock units. |
| 03/15/2029 | Second vesting date (50%) for the stock appreciation rights and restricted stock units. |
| 03/15/2030 | Expiration date for the stock appreciation rights. |
| 03/18/2025 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.